Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 4/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | FYN | P06241 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | CA3 | P07451 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31490381 | 1.00 | ESR1 (0.46) | ESR1ESR2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL2640042 | 1.00 | ESR1 (0.46) | ESR1ESR2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL444739 | 0.98 | ESR1 (0.44) | ESR1ESR2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL29415365 | 0.98 | ESR1 (0.44) | ESR1ESR2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL9838331 | 0.95 | ESR1 (0.43) | ESR1ESR2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL10513090 | 0.93 | ALDH1A1 (0.43) | ESR1ESR2ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL10514967 | 0.87 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1KDM4ENPC1CA12 | |
| SCHEMBL9327102 | 0.87 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1KDM4ENPC1CA12 | |
| SCHEMBL4552622 | 0.87 | ESR1 (0.50) | ESR1ESR2ALDH1A1L3MBTL1AKR1C1 | |
| SCHEMBL6838754 | 0.85 | ALDH1A1 (0.42) | ESR1ESR2ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 756 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118022642-A | High-durability thermochromic microcapsule based on multiple Pickering emulsion and preparation method thereof | 中国铁道科学研究院集团有限公司铁道建筑研究所 | 2024-05-14 | — | — | CN | claimed |
| CN-115298270-B | Method for preparing thermochromic water-based gel ink composition and thermochromic water-based gel ink composition thereof | 法国比克公司 | 2024-03-26 | — | — | CN | claimed |
| EP-3859211-B1 | HANDHELD LIGHTER WITH HIGH TEMPERATURE WARNING INDICATOR | SOCIéTé BIC (FR) | 2024-01-24 | — | — | EP | claimed |
| EP-3331959-B1 | ANIONIC CURABLE COMPOSITIONS | DESIGNER MOLECULES INC (US) | 2022-10-05 | — | — | EP | claimed |
| US-20220204696-A1 | PHENOLIC FUNCTIONALIZED POLYIMIDES AND COMPOSITIONS THEREOF | DESIGNER MOLECULES, INC | 2022-06-30 | — | — | US | claimed |
| WO-2020219852-A1 | PHENOLIC FUNCTIONALIZED POLYIMIDES AND COMPOSITIONS THEREOF | DESIGNER MOLECULES, INC. (US) | 2020-10-29 | — | — | WO | claimed |
| US-20180237668-A1 | ANIONIC CURABLE COMPOSITIONS | DESIGNER MOLECULES, INC. | 2018-08-23 | — | — | US | claimed |
| EP-3331959-A1 | ANIONIC CURABLE COMPOSITIONS | Designer Molecules, Inc. (US) | 2018-06-13 | — | — | EP | claimed |
| WO-2017027482-A1 | ANIONIC CURABLE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2017-02-16 | — | — | WO | claimed |
| EP-3087137-A1 | NOVEL ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION | BASF South East Asia Pte. Ltd. (SG) | 2016-11-02 | — | — | EP | claimed |
| US-20080081893-A1 | POLYCARBONATE-POLYSILOXANE COPOLYMERS, METHOD OF MAKING, AND ARTICLES FORMED THEREFROM | GENERAL ELECTRIC COMPANY (US) | 2008-04-03 | — | — | US | claimed |
| US-20080017308-A1 | Derivatives of poly(styrene-co-allyl alcohol) and methods for use thereof | DESIGNER MOLECULES, INC. | 2008-01-24 | — | — | US | claimed |
| US-20070299154-A1 | Mold compositions with high adhesion to metal substrates | DESIGNER MOLECULES, INC. | 2007-12-27 | — | — | US | claimed |
| US-6872858-B2 | Diphenol and process for producing the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2005-03-29 | — | — | US | claimed |
| US-20040049086-A1 | Diphenol and process for producing the same | HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) | 2004-03-11 | — | — | US | claimed |
| EP-1375461-A1 | DIPHENOL AND PROCESS FOR PRODUCING THE SAME | Honshu Chemical Industry Co. Ltd. (JP) | 2004-01-02 | — | — | EP | claimed |
| US-6211389-B1 | TREATING SPECIFICALLY DEFINED COMBINATIONS COMPRISING AN EPOXY RESIN STARTING MATERIAL AND OTHER COMPONENTS TO ORGANIC SOLVENT, A CROWN ETHER, AND A SUITABLE BASE TO CONDITIONS SUFFICIENT TO PRODUCE A TREATED EPOXY COMPOUND | DEXTER CORPORATION | 2001-04-03 | — | — | US | claimed |
| US-5604284-A | CONTAINING ALKALI METAL OR ALKALINE EARTH METAL HALIDE | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 1997-02-18 | — | — | US | claimed |
| EP-0567919-B1 | Epoxy resin composition and resin-encapsulated semiconductor device | SUMITOMO CHEMICAL CO (JP) | 1996-03-27 | — | — | EP | claimed |
| EP-0481287-B1 | Method for the production of substituted cyclohexylidenebisphenols | BAYER AG (DE) | 1996-01-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040049086-A1 | Diphenol and process for producing the same | CYP1A1, AHR, CYP2E1 | ESR1 489/4885ESR2 940/4885ALDH1A1 1259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.